Cellosaurus CCF-STTG1 (CVCL_1118)

Cell line name CCF-STTG1
Synonyms CCFSTTG1
Accession CVCL_1118
Resource Identification Initiative To cite this cell line use: CCF-STTG1 (RRID:CVCL_1118)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
Microsatellite instability: Stable (MSS) (Sanger).
Sequence variation: Has no IDH1 mutation (PubMed=19435942).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Astrocytoma (NCIt: C60781)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200; RCB

Markers:
AmelogeninX
CSF1PO12
D13S31711,13
D16S53911,12
D18S5115
D19S43315.2,16
D21S1128,29
D2S133820,26
D3S135816,17
D5S81812,13
D7S82010,11
D8S117913,14
FGA20,22
Penta D11,13
Penta E10
TH017,8
TPOX8,11
vWA17
Publications

PubMed=19435942; DOI=10.1215/15228517-2009-025
Ichimura K., Pearson D.M., Kocialkowski S., Backlund L.M., Chan R., Jones D.T.W., Collins V.P.
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Neuro-oncol. 11:341-347(2009)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections ATCC; CRL-1718
CLS; 300388/p721_CCF-STTG1
ECACC; 90021502
IZSLER; BS TCL 125
RCB; RCB1977 - Discontinued
Cell line databases/resources CLDB; cl669
CLDB; cl5177
CCLE; CCFSTTG1_CENTRAL_NERVOUS_SYSTEM
Cosmic-CLP; 906823
GDSC; 906823
IGRhCellID; CCFSTTG1
LINCS_LDP; LCL-1394
Ontologies BTO; BTO:0003863
CLO; CLO_0002329
EFO; EFO_0002127
Biological sample resources BioSample; SAMN01821545
BioSample; SAMN03470976
Chemistry resources ChEMBL-Cells; CHEMBL3308795
ChEMBL-Targets; CHEMBL1075419
Gene expression databases GEO; GSM326233
GEO; GSM886923
GEO; GSM887989
GEO; GSM1374443
GEO; GSM1669668
Polymorphism and mutation databases Cosmic; 687565
Cosmic; 849857
Cosmic; 897441
Cosmic; 906823
Cosmic; 920820
Cosmic; 1175808
Cosmic; 1610750
Cosmic; 1746959
Cosmic; 2302324
Cosmic; 2367511
Proteomic databases PRIDE; PXD003914